Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Inflammation01:38

Inflammation

56.1K
Overview
56.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

255
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
255
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Inflammatory Response01:28

Inflammatory Response

11.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
11.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Open-access clinic for arthralgia: patient flow and diagnostic pathways-a retrospective cohort study.

EULAR rheumatology open·2026
Same author

A safety checklist before initiating second-generation immunomodulating drugs for inflammatory dermatoses: a systematic review.

The Journal of dermatological treatment·2026
Same author

Uniting Quantum Processing Nodes of Cavity-Coupled Ions with Rare-Earth Quantum Repeaters Using Single-Photon Pulse Shaping Based on Atomic Frequency Comb.

Physical review letters·2026
Same author

Large soluble CD18 complexes with exclusive ICAM-1-binding properties are shed during immune cell migration in inflammation.

Journal of translational autoimmunity·2025
Same author

Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib.

Scientific reports·2025
Same author

The PerioGene North Study Uncovers Serum Proteins Related to Periodontitis.

Journal of dental research·2024

Related Experiment Video

Updated: Oct 9, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K

Nitro-fatty acids decrease type I interferons and monocyte chemoattractant protein 1 in ex vivo models of

A L Hansen1, L S J Rahbek1, A S Sørensen1

  • 1Department of Biomedicine, Aarhus University, Høegh-Guldbergs Gade 10, C. F. Møllers Allé 6, 8000, Aarhus C, Denmark.

BMC Immunology
|December 18, 2021
PubMed
Summary
This summary is machine-generated.

Nitro-fatty acid 10-NO2-oleic acid (10-NO2-OA) shows promise for treating inflammatory arthritis by reducing key inflammatory markers like MCP-1. This compound may offer a new therapeutic avenue for patients unresponsive to current treatments.

Keywords:
Antirheumatic drugArthritisAutoimmunityImmunosuppressive drugInflammationNitro-fatty acid

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

446
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

3.2K

Related Experiment Videos

Last Updated: Oct 9, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

446
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

3.2K

Area of Science:

  • Rheumatology
  • Immunology
  • Lipidomics

Background:

  • Inflammatory arthritis, including rheumatoid arthritis (RA) and spondyloarthritis (SpA), involves joint inflammation and destruction.
  • A significant portion of patients (approximately one-third) exhibit inadequate responses to initial therapeutic interventions.
  • Nitro-fatty acids, such as 10-NO2-oleic acid (10-NO2-OA), possess anti-inflammatory and tissue-protective properties.

Purpose of the Study:

  • To investigate the potential of 10-NO2-OA in mitigating immune responses implicated in the pathogenesis of inflammatory arthritis.
  • To evaluate the efficacy of 10-NO2-OA in preclinical models of RA and SpA.

Main Methods:

  • Synovial fluid and blood samples were collected from 14 patients diagnosed with active RA or SpA.
  • In vitro models included synovial fluid mononuclear cells (SFMCs) cultured for 48 hours and 21 days, and fibroblast-like synovial cells (FLSs) co-cultured with peripheral blood mononuclear cells (PBMCs).
  • Cells were treated with 10-NO2-OA or etanercept, a TNFα inhibitor, and supernatants were analyzed for inflammatory markers (type I interferon, MCP-1, MMP3, TRAP).

Main Results:

  • 10-NO2-OA demonstrated a dose-dependent reduction in type I interferons and MCP-1 in SFMCs cultured for 48 hours.
  • In SFMCs cultured for 21 days, 10-NO2-OA significantly decreased MCP-1 production.
  • In FLS-PBMC co-cultures, 10-NO2-OA markedly reduced MCP-1 production, an effect not observed with etanercept.

Conclusions:

  • 10-NO2-OA effectively reduced MCP-1 release across multiple inflammatory arthritis models.
  • The compound also inhibited type I interferon production and showed superior efficacy in reducing MCP-1 in FLS-dominant cultures compared to etanercept.
  • These findings support further clinical investigation of 10-NO2-OA for managing inflammatory arthritis.